Clinical Trial Update: Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the safety of a quadruple chemotherapy combination (irinotecan with 5-FU/leucovorin, oxaliplatin, and docetaxel) in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma
• Pancreatic Adenocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Camptosar (irinotecan)
• Eloxatin (oxaliplatin)
• Leucovorin (folinic acid)
• Taxotere (docetaxel)

Snippet

Sponsor: University of Chicago | Conditions: Pancreatic Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 1 | Status: RECRUITING